Statement on the reported waste of $9.7 million worth of USAID contraception

Policy and advocacy   |   30 March 2026   |   2 min read

Share






Copied


Responding to reports in the New York Times that $9.7m worth of USAID contraception has been left in a warehouse and become unusable, Beth Schlachter, MSI Reproductive Choices’ Senior Director of External Relations and Advocacy, said:

“Reports that millions of dollars’ worth of USAID-funded contraceptive supplies destined for low-income nations in Africa have become unusable raise serious concerns. MSI and partners had offered to pay for the shipment and distribution of the supplies, at no additional cost to the US taxpayer, but the Trump administration rejected our offers. While the full circumstances remain unclear, what is evident is that the US government has left essential medical supplies to gather dust instead of allowing them to get to the people who desperately need them at a time of acute global need.

“This is yet one more egregious example of the chaos, confusion and harm caused by decisions driven by political considerations rather than public health priorities. This wanton waste will only add to the suffering of women and girls facing empty shelves and an uncertain future.”


Note to Editor 

For interviews and further information please contact: 

Email: [email protected]  

Tel: +44 (0)7769 166 516  


Share






Copied

Related posts

News


21 May 2026   |   2 min read

Statement on UK government’s new international effort to drive progress for women and girls

MSI statement on the UK government’s new International Strategic Framework on Women and Girls, and a new

News


20 May 2026   |   1 min read

Statement on study showing that U.S. abortion bans restrict miscarriage care

MSI statement on a new study finding that abortion bans in the US are restricting miscarriage care.

News


15 May 2026   |   4 min read

MSI statement on U.S. legal actions to restrict access to mifepristone

A recent U.S. federal court ruling restricting access to mifepristone is not grounded in medical evidence and fuels